Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group (Q74509254)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1998

Language	Label	Description	Also known as
English	Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group	scientific article published on 01 March 1998

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

United States of America

1 reference

based on heuristic

inferred from title

1

object named as

R N Jones

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Michael A. Pfaller

2

object named as

M A Pfaller

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Meridith E. Erwin

4

object named as

M E Erwin

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

G V Doern

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R J Hollis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

215-228

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the E test, a novel method of quantifying antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Is it important to identify extended-spectrum beta-lactamase-producing isolates?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefepime as treatment for osteomyelitis and other severe bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of FK-037, a new parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A new therapeutic option for the treatment of pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and structure-activity relationships of a new series of cephalosporins, BMY-28142 and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of cefepime: a new extended-spectrum parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Current and future management of serious skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900234-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(97)00234-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572029%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74509254&oldid=1959764559"